Références
Aapro M, Bernard-Marty C, Brain EG, et al. (2011) Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Ann Oncol 22(2): 257–267
Barnadas A, Gil M, González S, et al. (2009) Exemestane as primary treatment of estrogen receptor-positive breast cancer in postmenopausal women: a phase II trial. Br J Cancer 100(3): 442–449. Epub 2009 Jan 20
Bear HD (2010) Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy. Surg Oncol Clin N Am 19(3): 607–626
Brain EG, Mertens C, Girre V, et al. (2011) Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: a French Geriatric Oncology Group (GERICO) phase II multicentre trial. Crit Rev Oncol Hematol 80(1): 160–170
Chia YH, Ellis MJ, Ma CX (2010) Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool. Br J Cancer 103(6): 759–764. Epub 2010 Aug 10
Dixon JM, Renshaw L, Macaskill EJ, et al. (2009) Increase in response rate by prolonged treatment with neoadjuvant letrozole. Breast Cancer Res Treat 113(1): 145–151. Epub 2008 Feb 9
Ellis MJ, Miller WR, Tao Y et al. (2009) Aromatase expression and out-comes in the P024 neoadjuvant endocrine therapy trial. Breast Cancer Res Treat 116(2): 371–378. Epub 2008 Oct 22
Ellis MJ, Tao Y, Luo J, et al. (2008) Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. J Natl Cancer Inst 100(19): 1380–1388. Epub 2008 Sep 23
Galimberti V, Botteri E, Chifu C, et al. (2011) Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res Treat DOI:10.1007/s10549-011-1486-2-Published on line
Lee SJ, Lindquist K, Segal MR, et al. (2006) Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295(7): 801–808
Luciani A, Ascione G, Bertuzzi C, et al. (2010) Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. JCO 28(12): 2046–2050
Mello-Grand M, Singh V, Ghimenti C, et al. (2010) Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer. Breast 121(2): 399–411. Epub 2010 Apr 29
Miller WR (2009) Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer. J Steroid Biochem Mol Biol 118(4–5): 273–276
Molina-Garrido MJ, Guillen-Ponce C (2011) Comparison of two frailty screening tools in older women with early breast cancer. Crit Rev Oncol Hematol 79: 51–64
Overcash JA, Beckstead J, Extermann M, Cobb S (2005) The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol 54: 129–136
Seo JH, Kim YH, Kim JS (2009) Meta-analysis of preoperative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer. Cancer Chemother Pharmacol 63(2): 261–266. Epub 2008 Mar 26
Soubeyran P, Bellera C, Goyard J, et al. (2011) Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project. J Clin Oncol 29 (suppl; abstr 9001)
Veronesi U, Marubini E, Mariani L, et al. (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12(7): 997–1003
Viehl CT, Langer I, Guller U, et al. (2011) Prognostic impact and therapeutic implications of sentinel lymph node micrometastases in early-stage breast cancer patients. J Surg Oncol 103(6): 531–533
About this article
Cite this article
Brain, É., Carola, É., Falandry, C. et al. Le cancer du sein de la femme âgée (hors situation métastatique). Oncologie 13, 755–757 (2011). https://doi.org/10.1007/s10269-011-2079-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10269-011-2079-8